Literature DB >> 28872135

Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction.

Mychal S Grames1, Kasey L Jackson1, Robert D Dayton1, John A Stanford2, Ronald L Klein3.   

Abstract

Adeno-associated virus (AAV) vectors are a key reagent in the neurosciences for clustered regularly interspaced short palindromic repeats (CRISPR), optogenetics, cre-lox targeting, etc. The purpose of this manuscript is to aid the investigator attempting expansive central nervous system (CNS) gene transfer in the rat via tail vein injection of AAV. Wide-scale expression is relevant for conditions with widespread pathology, and a rat model is significant due to its greater size and physiologic similarities to humans compared to mice. In this example application, a wide-scale neuronal transduction is used to mimic a neurodegenerative disease that affects the entire spinal cord, amyotrophic lateral sclerosis (ALS). The efficient wide-scale CNS transduction can also be used to deliver therapeutic protein factors in pre-clinical studies. After a post-injection expression interval of several weeks, the effects of the transduction are evaluated. For a green fluorescent protein (GFP) control vector, the amount of GFP in the cerebellum is estimated quickly and reliably by a basic imaging program. For motor disease phenotypes that are induced by the ALS related protein transactive response DNA-binding protein of 43 kDa (TDP-43), the deficits are scored by escape reflex and rotarod. Beyond disease modeling and gene therapy, there are diverse potential applications for the wide-scale gene targeting described here. The expanded use of this method will aid in expediting hypothesis testing in the neurosciences and neurogenetics.

Entities:  

Mesh:

Year:  2017        PMID: 28872135      PMCID: PMC5614388          DOI: 10.3791/55994

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  12 in total

1.  CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice.

Authors:  L Xu; T Daly; C Gao; T R Flotte; S Song; B J Byrne; M S Sands; K Parker Ponder
Journal:  Hum Gene Ther       Date:  2001-03-20       Impact factor: 5.695

2.  Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed.

Authors:  David B Wang; Robert D Dayton; Phillip P Henning; Cooper D Cain; Li Ru Zhao; Lisa M Schrott; Elysse A Orchard; David S Knight; Ronald L Klein
Journal:  Mol Ther       Date:  2010-09-28       Impact factor: 11.454

3.  Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons.

Authors:  Sandra Duque; Béatrice Joussemet; Christel Riviere; Thibaut Marais; Laurence Dubreil; Anne-Marie Douar; John Fyfe; Philippe Moullier; Marie-Anne Colle; Martine Barkats
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

4.  Gene vector 'magic bullet': targeted expression in the central nervous system after peripheral delivery using the synapsin promoter.

Authors:  Kasey L Jackson; Robert D Dayton; Ronald L Klein
Journal:  Expert Opin Ther Targets       Date:  2016-07-25       Impact factor: 6.902

5.  Intravenous injections in neonatal mice.

Authors:  Sara E Gombash Lampe; Brian K Kaspar; Kevin D Foust
Journal:  J Vis Exp       Date:  2014-11-11       Impact factor: 1.355

6.  Preservation of forelimb function by UPF1 gene therapy in a rat model of TDP-43-induced motor paralysis.

Authors:  K L Jackson; R D Dayton; E A Orchard; S Ju; D Ringe; G A Petsko; L E Maquat; R L Klein
Journal:  Gene Ther       Date:  2014-11-06       Impact factor: 5.250

7.  Selective forelimb impairment in rats expressing a pathological TDP-43 25 kDa C-terminal fragment to mimic amyotrophic lateral sclerosis.

Authors:  Robert D Dayton; Michael A Gitcho; Elysse A Orchard; Jon D Wilson; David B Wang; Cooper D Cain; Jeffrey A Johnson; Yong-Jie Zhang; Leonard Petrucelli; J Michael Mathis; Ronald L Klein
Journal:  Mol Ther       Date:  2013-05-21       Impact factor: 11.454

Review 8.  Gas embolism: pathophysiology and treatment.

Authors:  Robert A van Hulst; Jan Klein; Burkhard Lachmann
Journal:  Clin Physiol Funct Imaging       Date:  2003-09       Impact factor: 2.273

9.  Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B.

Authors:  Kasey L Jackson; Robert D Dayton; Benjamin E Deverman; Ronald L Klein
Journal:  Front Mol Neurosci       Date:  2016-11-04       Impact factor: 5.639

10.  AAV9 supports wide-scale transduction of the CNS and TDP-43 disease modeling in adult rats.

Authors:  Kasey L Jackson; Robert D Dayton; Ronald L Klein
Journal:  Mol Ther Methods Clin Dev       Date:  2015-09-30       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.